Stocks Explorer
Stocks
Sectors
Search
Precigen, Inc.(PGEN) News
Profile
Chart
News
Analysis
Holders
PGEN price today
by TradingView
Date
Title
Aug 9
Precigen Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated Approval
‹ Prev
Page
of 2
Next ›